How Ochsner Health turned supply chain data into a procedural performance advantage
Unprecedented growth creates unprecedented complexity. As Ochsner Health expanded to 47 hospitals across the Gulf South, medical device spend climbed 141% between 2018 and 2024 — and a growing share of procedural spend remained invisible to the teams managing it.
Vizient Procedural Analytics changed that. Deployed in 2022, it delivered immediate visibility into $500 million in clinical consumption — transforming unidentified spend from a persistent gap into a solvable problem. By 2024, Ochsner Health reduced unidentified procedural spend from 9% to 5%, even as total spend grew 42%.
In this report, Ochsner Health supply chain leaders show how the right solution, data integrity, governance, and physician partnership accelerate transformation at scale.
You'll learn:
Vizient Procedural Analytics changed that. Deployed in 2022, it delivered immediate visibility into $500 million in clinical consumption — transforming unidentified spend from a persistent gap into a solvable problem. By 2024, Ochsner Health reduced unidentified procedural spend from 9% to 5%, even as total spend grew 42%.
In this report, Ochsner Health supply chain leaders show how the right solution, data integrity, governance, and physician partnership accelerate transformation at scale.
You'll learn:
- How to expose unwarranted variation and strengthen procedural margins, while protecting patient outcomes
- How trusted data supports faster, more confident perioperative decisions
- Why physician champions are central to standardization and how to include them in the work
Please fill out the form to download the whitepaper.